Skip to Content


In the US, Bendamustine (bendamustine systemic) is a member of the drug class alkylating agents and is used to treat Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Cytostatic alkylating agent

Chemical Name

5-[bis(2-chloroetyl)amino]-1-metyl-2-benzimidazolebutyric acid (WHO)

Foreign Names

  • Bendamustinum (Latin)
  • Bendamustin (German)
  • Bendamustine (French)
  • Bendamustina (Spanish)

Generic Names

  • Bendamustine (OS: BAN)
  • CIMET 3393 (IS)
  • IMET 3393 (IS)
  • UNII-9266D9P3PQ (IS)
  • Bendamustine Hydrochloride (OS: USAN, JAN, BANM)
  • SDX 105 (IS)
  • SyB L-0501 (IS)
  • UNII-981Y8SX18M (IS)

Brand Names

  • Levact
    Astellas, Slovakia
  • Mustin
    RPG, India
  • Ribomustin
    Astellas, Bosnia & Herzegowina; Janssen, Chile; Temmler, Georgia
  • Bendamustina Accord
    Accord, Spain
  • Bendamustine Accord
    Accord Healthcare, Poland
  • Bendamustine Actavis
    Actavis Group, Poland
  • Bendamustine Helm
    Helm, Poland
  • Bendamustine Intas
    Intas, Poland
  • Bendamustine Medac
    medac, Estonia
    Teva, United States
  • Levact
    Astellas, Iceland; Astellas, Italy; Astellas, Portugal; Astellas Pharma, Austria; Astellas Pharma, Poland; Astellas Pharma Europe, Netherlands; Eureco-Pharma, Netherlands; Mundipharma, Belgium; Mundipharma, Germany; Mundipharma, Spain; Mundipharma, Finland; Mundipharma, France; Mundipharma, Ireland; Mundipharma, Netherlands; Mundipharma, Norway; Napp Pharmaceuticals, United Kingdom; norpharma, Denmark; Temmler, Bulgaria
  • Lynetoril
    Chiesi, Slovakia; Chiesi Pharmaceuticals, Poland
  • Rhomustin
    Helm, Bulgaria; Helm, Poland
  • Ribomustin
    Astellas, South Africa; Janssen Cilag, Argentina; Janssen-Cilag, Colombia; Mundipharma, Switzerland; Temmler, Georgia; Temmler Werke, Israel
  • Ribovact
    Mundipharma, Sweden
  • Symbenda
    Eisai, South Korea
  • Treakisym
    SymBio Pharmaceuticals, Japan
  • Treanda
    Cephalon, United States; Lundbeck, Canada; Teva, Hong Kong


BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.